BCL2 and breast carcinoma: In addition, our data pointed out that the expression of anti-apoptotic marker, Bcl-2 was lost when treated with PAMAM dendrimers suggesting that PAMAM dendrimers induce apoptotic activity in breast cancer cell lines.